ORIGINAL PAPER
Anxiety and depression in primary knee osteoarthritis patients: are they related to clinical features and radiographic changes?
More details
Hide details
1
Department of Rheumatology and Rehabilitation, Faculty of Medicine, Cairo University, Kasr Alainy Hospital, Cairo, Egypt
Submission date: 2024-03-05
Final revision date: 2024-07-31
Acceptance date: 2024-10-23
Publication date: 2024-12-24
Corresponding author
Marwa H. Niazy
Department of Rheumatology and Rehabilitation, Faculty of Medicine, Cairo University, Kasr Alainy Hospital, Governorate 11956, Cairo, Egypt
Reumatologia 2024;62(6):421-429
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Osteoarthritis (OA) is a worldwide, disabling condition, more prevalent in older people. Although anxiety and depression disorders are common in OA and may affect compliance with treatment, both disorders are still underrecognized and undertreated. The present study aimed to screen for anxiety and depression among patients with primary knee OA, and to study the relationship between Hospital Anxiety and Depression Scale (HADS) score and different disease parameters.
Material and methods:
Fifty patients fulfilling primary knee OA classification criteria were recruited for the study, and 50 age- and sex-matched healthy individuals served as a control group. Medical history was taken, clinical examination was done, and pain intensity was assessed using the Visual Analogue Scale. The 6-minute walk test was used for functional status assessment, and plain X-ray knees were scored according to the Kellgren and Lawrence classification system. Participants completed the HADS questionnaire.
Results:
Twenty-nine patients were female (58%) and 21 were male (42%). The mean HADS score was significantly higher in OA patients than controls (p = 0.001). The mean HADS-A (Anxiety) score was statistically significantly higher in OA patients than controls (p < 0.001). Anxiety was more frequent in patients (44%) than in controls (10%) (p < 0.001). In regression analysis, female sex could be considered as a predictor for each of HADS-A and HADS-D (Depression) (b: 0.4, 0.3; t: 3.28, 2.2; p = 0.002, 0.03; CI: 1.3–5.6, 0.2–4.4), respectively, while knee giving way was considered as a predictor for HADS-A (b: 0.34, t: 2.8, p = 0.007, CI: 0.96–5.87).
Conclusions:
The results of the present study showed that anxiety level rather than depression was significantly higher in patients with primary knee OA than in controls. Female sex could be considered as a predictor for each of HADS-A and HADS-D, while knee giving way was considered as a predictor for HADS-A.
REFERENCES (43)
1.
Comblain F, Dubuc JE, Lambert C, et al. Identification of targets of a new nutritional mixture for osteoarthritis management composed by curcuminoids extract, hydrolyzed collagen and green tea extract. PLoS One 2016; 11: e0156902, DOI: 10.1371/journal.pone.0156902.
2.
Testa G, Giardina SMC, Culmone A, et al. Intra-articular injections in knee osteoarthritis: a review of literature. J Funct Morphol Kinesiol 2021; 6: 15, DOI: 10.3390/jfmk6010015.
3.
Qian J, Fu P, Li S, et al. miR-107 affects cartilage matrix degradation in the pathogenesis of knee osteoarthritis by regulating caspase-1. J Orthop Surg Res 2021; 16: 40, DOI: 10.1186/s13018-020-02121-7.
4.
Lee H, Zhao X, Son YO, Yang S. Therapeutic single compounds for osteoarthritis treatment. Pharmaceuticals (Basel) 2021; 14: 131, DOI: 10.3390/ph14020131.
5.
Alrushud AS, El-Sobkey SB, Hafez AR, Al-Ahaideb A. Impact of knee osteoarthritis on the quality of life among Saudi elders: a comparative study. Saudi Journal of Sports Medicine 2013; 13: 10–16, DOI: 10.4103/1319-6308.112207.
6.
Yang RZ, Zheng HL, Xu WN, et al. Vascular endothelial cell-secreted exosomes facilitate osteoarthritis pathogenesis by promoting chondrocyte apoptosis. Aging (Albany NY) 2021; 13: 4647–4662, DOI: 10.18632/aging.202506.
7.
Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003; 54: 216–226, DOI: 10.1016/s0006- 3223(03)00273-7.
8.
Weiss F, Barbuti M, Carignani G, et al. Psychiatric aspects of obesity: A narrative review of pathophysiology and psychopathology. J Clin Med 2020; 9: 2344, DOI: 10.3390/jcm9082344.
9.
Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 2005; 62: 593–602, DOI: 10.1001/archpsyc.62.6.593.
10.
Sopian MM, Abbas S, Teoh SH, el al. Mental health and obesity: A narrative review. Pakistan Journal of Medical and Health Sciences 2021; 15: 1468–1473, DOI: 10.53350/pjm hs211551468.
11.
Axford J, Butt A, Heron C, et al. Prevalence of anxiety and depression in osteoarthritis: use of the Hospital Anxiety and Depression Scale as a screening tool. Clin Rheumatol 2010; 29: 1277–1283, DOI: 10.1007/s10067-010-1547-7.
12.
Sharma A, Kudesia P, Shi Q, Gandhi R. Anxiety and depression in patients with osteoarthritis: impact and management challenges. Open Access Rheumatol 2016; 8: 103–113, DOI: 10.2147/OARRR.S93516.
13.
Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361–370, DOI: 10.1111/j.1600-0447.1983.tb09716.x.
14.
Muszbek K, Szekely A, Balogh EM, et al. Validation of the Hungarian translation of Hospital Anxiety and Depression Scale. Qual Life Res 2006; 15: 761–766, DOI: 10.1007/s11136-005-3627-8.
15.
Herrmann C. International experiences with the Hospital Anxiety and Depression Scale – a review of validation data and clinical results. J Psychosom Res 1997; 42: 17–41, DOI: 10.1016/s0022-3999(96)00216-4.
16.
Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986; 29: 1039–1049, DOI: 10.1002/art.1780290816.
17.
World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. World Health Organ Tech Rep Ser 2000; 894: i–xii,1–253.
18.
Delgado DA, Lambert BS, Boutris N, et al. Validation of digital Visual Analog Scale pain scoring with a traditional paper-based Visual Analog Scale in adults. J Am Acad Orthop Surg Glob Res Rev 2018; 2: e088, DOI: 10.5435/JAAOSGlobal-D-17-00088.
19.
Chetta A, Zanini A, Pisi G, et al. Reference values for the 6-min walk test in healthy subjects 20-50 years old. Respir Med 2006; 100: 1573–1578, DOI: 10.1016/j.rmed.2006.01.001.
20.
Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16: 494–502, DOI: 10.1136/ard. 16.4.494.
21.
Igwesi-Chidobe CN, Muomah RC, Sorinola IO, Godfrey EL. Detecting anxiety and depression among people with limited literacy living with chronic low back pain in Nigeria: adaptation and validation of the hospital anxiety and depression scale. Arch Public Health 2021; 79: 72, DOI: 10.1186/s13690-021-00586-4.
22.
Djukanovic I, Carlsson J, Årestedt K. Is the Hospital Anxiety and Depression Scale (HADS) a valid measure in a general population 65-80 years old? A psychometric evaluation study. Health Qual Life Outcomes 2017; 15: 193, DOI: 10.1186/s12955-017-0759-9.
23.
Terkawi AS, Tsang S, AlKahtani GJ, et al. Development and validation of Arabic version of the Hospital Anxiety and Depression Scale. Saudi J Anaesth 2017; 11 (Suppl 1): S11–S18, DOI: 10.4103/sja.SJA_43_17.
24.
Hu Y, Zhan G. Anxiety and depression prevalence and their risk factors in lupus nephritis patients: a case-control study. Immun Inflamm Dis 2022; 10: e689, DOI: 10.1002/iid3.689.
25.
Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron 2020; 107: 234–256, DOI: 10.1016/j.neuron.2020.06.002.
26.
Uguz F, Akman C, Kucuksarac S, Tufekci O. Anti-tumor necrosis factor-alpha therapy is associated with less frequent mood and anxiety disorders in patients with rheumatoid arthritis. Psychiatry Clin Neurosci 2009; 63: 50–55, DOI: 10.1111/j.1440-1819.2008.01905.x.
27.
Yang X, Guan Y, Tian S, et al. Mechanical and IL-1 responsive miR-365 contributes to osteoarthritis development by targeting histone deacetylase 4. Int J Mol Sci 2016; 17: 436, DOI: 10.3390/ijms17040436.
28.
Ferreira AH, Godoy PB, Oliveira NR, et al. Investigation of depression, anxiety and quality of life in patients with knee osteoarthritis: a comparative study. Rev Bras Reumatol 2015; 55: 434–438, DOI: 10.1016/j.rbr.2015.03.001.
29.
Axford J, Heron C, Ross F, Victor CR. Management of knee osteoarthritis in primary care: pain and depression are the major obstacles. J Psychosom Res 2008; 64: 461–467, DOI: 10.1016/j.jpsychores.2007.11.009.
30.
Shalaby AS, El-Sayed AS. Anxiety, depression, and quality of life in patients with knee osteoarthritis before and after knee joint replacement. Egypt J Psychiatr 2017; 38: 8–12, DOI: 10.4103/1110-1105.200714.
31.
Kulu M, Ozsoy F, Korkmaz M. [Levels of anxiety depression and somatosensory amplification in patients with osteoarthritis]. Cumj 2020; 45: 688–694, DOI: 10.17826/cumj.697988 [Article in Turkish].
32.
Wong LY, Yiu RL, Chiu CK, et al. Prevalence of psychiatric morbidity in Chinese subjects with knee osteoarthritis in a Hong Kong orthopaedic clinic. East Asian Arch Psychiatry 2015; 25: 150–158.
33.
Nazarinasab M, Motamedfar A, Moqadam AE. Investigating mental health in patients with osteoarthritis and its relationship with some clinical and demographic factors. Reumatologia 2017; 55: 183–188, DOI: 10.5114/reum.2017.69778.
34.
Park HM, Kim HS, Lee YJ. Knee osteoarthritis and its association with mental health and health-related quality of life: a nationwide cross-sectional study. Geriatr Gerontol Int 2020; 20: 379–383, DOI: 10.1111/ggi.13879.
35.
Husnain A, Khan A, Aziz T, Hussain FN. Anxiety and depression in osteoarthritis patients using HADS questionnaire. RMJ 2021; 46: 56–61.
36.
Duarte N, Rodrigues AM, Branco JC, et al. Health and lifestyles factors associated with osteoarthritis among older adults in Portugal. Front Med (Lausanne) 2017; 4: 192, DOI: 10.3389/fmed.2017.00192.
37.
Rosemann T, Backenstrass M, Joest K, et al. Predictors of depression in a sample of 1,021 primary care patients with osteoarthritis. Arthritis Rheum 2007; 57: 415–422, DOI: 10.1002/art.22624.
38.
Prado LD, Ramos ME, Camargo JD, et al. Relationship between pain, functional limitations, dependence, depression and osteoarthritis in older adults. Fisioterapia em Movimento 2023; 36: e36202, DOI: 10.1590/fm.2023.36202.
39.
Kroenke K, Wu J, Bair MJ, et al. Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care. J Pain 2011; 12: 964–973, DOI: 10.1016/j.jpain. 2011.03.003.
40.
Sayre EC, Esdaile JM, Kopec JA, et al. Specific manifestations of knee osteoarthritis predict depression and anxiety years in the future: Vancouver Longitudinal Study of Early Knee Osteoarthritis. BMC Musculoskelet Disord 2020; 21: 467, DOI: 10.1186/s12891-020-03496-8.
41.
Alabajos-Cea A, Herrero-Manley L, Suso-Martí L, et al. Are psychosocial factors determinant in the pain and social participation of patients with early knee osteoarthritis? A cross-sectional study. Int J Environ Res Public Health 2021; 18: 4575. DOI: 10.3390/ijerph18094575.
42.
Rathbun AM, Shardell MD, Stuart EA, et al. Pain severity as a mediator of the association between depressive symptoms and physical performance in knee osteoarthritis. Osteoarthritis Cartilage 2018; 26: 1453–1460, DOI: 10.1016/j.joca.2018.07.016.
43.
García-López S, Llopart-Carles N, Castro-Domínguez F, Rejas- Gutierrez J. Patient self-reported functioning by pain severity and usual analgesic treatment among older adults with osteoarthritis: analysis of the 2017 Spanish National Health Survey. Eur Geriatr Med 2021; 12: 989–1001, DOI: 10.1007/s41999-021-00488-2.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.